IHS Chemical Week

People & Business :: M&A

Shasun Pharmaceuticals to sell Vizag plant

7:03 AM MST | December 12, 2013 | Natasha Alperowicz

Shasun Pharmaceuticals (Chennai, India), a leading global supplier of intermediates, active pharma ingredients (APIs) and formulations, announced today that its board of directors has approved plans to divest its Vizag, India, manufacturing  facility subject to approval from shareholders. The company announced in 2009 that it plans to build the facility with an initial production capacity of 1,200 m.t./year of bulk drugs, including generic APIs, particularly for the Japanese market. Completion of the facility was delayed several times due to several reasons...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa